Sangbin Lee

Project Leader
GC Biopharma Corp.
Yongin, Kyonggi-do, Republic of Korea

Presentation(s):

• PB1320 - A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MG1113 in Healthy Subjects and Hemophilia Patients

  Tuesday, June 27, 2023
  18:30 – 19:30 ET